Table 2.8.a. Serum trans-lycopene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged3 years and older, National Health and Nutrition Examination Survey, 2001–2002.
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S.population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.
Geometric mean (95% conf. interval)
Selected percentiles (95% conf. interval)
Sample size
10th
50th
90th
Males and Females
Total, 3 years and older
19.7
(18.9-20.5)
10.6
(9.90-11.6)
20.6
(19.8-21.5)
34.6
(33.0-36.0)
2111
3–5 years
15.0
(12.9-17.4)
7.30
(5.80-9.20)
15.7
(12.5-19.4)
30.4
(23.0-39.8)
124
6–11 years
19.7
(18.3-21.3)
10.5
(9.20-13.1)
20.5
(18.7-22.5)
33.7
(29.6-36.1)
289
12–19 years
20.4
(19.4-21.4)
12.3
(11.2-13.4)
20.7
(19.6-22.0)
32.9
(30.4-36.2)
696
20–39 years
21.4
(20.1-22.8)
12.1
(11.2-13.6)
21.7
(20.6-22.5)
36.0
(33.1-39.9)
460
40–59 years
19.1
(17.5-20.9)
10.2
(8.70-11.3)
20.0
(17.9-22.3)
34.4
(29.9-39.1)
287
60 years and older
13.9
(11.7-16.6)
6.20
(2.20-9.60)
15.3
(13.1-17.7)
30.1
(26.6-31.6)
255
Males
Total, 3 years and older
20.4
(19.6-21.2)
11.4
(10.2-12.0)
21.3
(20.6-21.9)
35.9
(32.7-39.4)
1018
3–5 years
15.2
(13.3-17.2)
8.60†
(1.80-11.3)
15.7
(12.4-18.1)
28.5†
(23.8-33.3)
62
6–11 years
20.8
(18.5-23.4)
12.6
(8.70-14.7)
20.6
(19.2-24.1)
33.4
(28.4-45.7)
140
12–19 years
21.1
(20.2-22.0)
12.9
(11.6-13.9)
21.5
(20.4-22.6)
34.6
(30.3-39.4)
330
20–39 years
22.0
(20.7-23.5)
12.4
(11.2-14.1)
22.2
(20.7-23.6)
39.1
(33.0-43.7)
213
40–59 years
20.0
(17.9-22.3)
10.2
(8.90-11.8)
20.9
(16.8-24.5)
35.5
(30.2-43.3)
147
60 years and older
13.0
(10.4-16.3)
5.20
(.800-7.50)
14.2
(10.6-17.7)
27.8
(24.0-31.4)
126
Females
Total, 3 years and older
19.0
(18.0-20.0)
10.2
(9.10-11.3)
20.0
(18.6-21.4)
33.7
(31.6-34.9)
1093
3–5 years
14.8
(11.0-19.8)
6.70†
(4.30-9.50)
15.0
(9.50-22.8)
32.7†
(20.3-37.9)
62
6–11 years
18.7
(16.8-20.7)
9.90
(9.10-11.0)
20.0
(16.9-22.9)
33.2
(28.6-35.4)
149
12–19 years
19.6
(18.4-20.9)
11.7
(10.2-13.6)
19.8
(18.3-21.2)
31.7
(29.7-35.9)
366
20–39 years
20.6
(18.9-22.5)
11.6
(10.3-13.2)
21.3
(19.0-22.7)
34.8
(30.1-37.6)
247
40–59 years
18.2
(16.4-20.2)
9.10
(5.30-13.2)
19.3
(17.9-20.8)
30.5
(28.2-36.9)
140
60 years and older
14.7
(12.1-18.0)
6.80
(1.90-10.3)
15.8
(13.7-20.7)
30.5
(24.4-36.1)
129
† Estimate is subject to greater uncertainty due to small cell size.
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S.population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.
Geometric mean (95% conf. interval)
Selected percentiles (95% conf. interval)
Sample size
10th
50th
90th
Males and Females
Total, 3 years and older
21.6
(21.0-22.3)
10.9
(10.1-11.7)
23.4
(22.1-24.2)
40.1
(37.9-42.2)
1992
3–5 years
20.8
(18.3-23.6)
10.9
(8.90-13.4)
20.8
(18.6-24.9)
40.9
(28.5-54.9)
128
6–11 years
25.9
(24.1-27.9)
15.0
(13.1-16.8)
27.1
(24.1-29.6)
42.1
(36.7-47.1)
340
12–19 years
24.7
(23.6-25.8)
13.9
(12.4-16.0)
25.4
(24.0-27.0)
41.0
(38.4-43.0)
671
20–39 years
24.3
(23.3-25.4)
13.1
(12.4-14.6)
25.2
(23.5-26.8)
41.6
(39.0-46.9)
319
40–59 years
19.0
(17.7-20.5)
8.70
(6.20-11.3)
20.6
(19.6-22.0)
35.9
(34.4-41.3)
291
60 years and older
14.1
(12.9-15.4)
5.40
(4.50-7.10)
14.5
(13.3-16.7)
31.4
(28.8-34.1)
243
Males
Total, 3 years and older
22.3
(21.4-23.2)
10.7
(9.90-12.4)
23.8
(22.8-24.6)
41.2
(37.4-44.1)
984
3–5 years
21.6
(18.2-25.5)
9.90†
(5.10-15.1)
23.8
(19.3-27.0)
41.7†
(30.5-57.7)
64
6–11 years
27.1
(24.3-30.1)
15.9
(13.0-18.5)
28.0
(23.9-32.2)
44.0
(36.4-49.1)
175
12–19 years
25.1
(23.9-26.4)
15.2
(13.4-16.7)
25.9
(24.4-27.6)
40.1
(36.8-44.6)
340
20–39 years
25.6
(24.4-26.9)
14.2
(12.5-16.2)
26.5
(23.8-28.1)
45.3
(37.4-56.2)
132
40–59 years
19.4
(17.8-21.0)
9.20
(6.20-11.2)
21.3
(19.3-22.7)
35.7
(32.4-41.2)
154
60 years and older
13.5
(11.8-15.4)
5.40
(4.30-7.10)
14.0
(11.4-16.4)
30.9
(26.2-34.9)
119
Females
Total, 3 years and older
21.1
(20.2-22.0)
11.0
(10.1-11.6)
22.6
(20.9-24.2)
39.7
(37.1-41.3)
1008
3–5 years
20.0
(17.2-23.2)
11.1†
(7.60-14.4)
19.6
(15.7-25.5)
40.9†
(26.3-44.6)
64
6–11 years
24.7
(22.7-26.9)
13.8
(11.7-16.8)
25.9
(23.6-28.2)
39.2
(35.2-44.8)
165
12–19 years
24.3
(22.7-26.0)
12.5
(11.3-15.8)
25.2
(22.7-27.6)
41.0
(38.8-44.4)
331
20–39 years
23.5
(22.1-25.0)
13.0
(11.8-14.6)
24.4
(22.1-26.6)
39.7
(37.1-46.5)
187
40–59 years
18.7
(16.9-20.7)
7.90
(5.40-11.9)
19.9
(17.7-22.0)
36.2
(30.9-43.9)
137
60 years and older
14.5
(12.8-16.5)
5.60
(4.50-8.20)
14.8
(12.5-18.6)
31.4
(28.0-34.1)
124
† Estimate is subject to greater uncertainty due to small cell size.
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the U.S.population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002.
Geometric mean (95% conf. interval)
Selected percentiles (95% conf. interval)
Sample size
10th
50th
90th
Males and Females
Total, 3 years and older
20.7
(19.9-21.4)
10.8
(10.2-11.4)
22.1
(21.0-23.2)
37.6
(36.3-38.7)
3578
3–5 years
15.4
(14.0-17.0)
7.90
(6.20-9.30)
16.6
(14.8-17.9)
27.5
(25.3-31.2)
132
6–11 years
21.5
(20.2-22.9)
11.4
(9.70-13.2)
22.2
(20.6-23.6)
35.8
(33.3-37.8)
300
12–19 years
21.1
(20.5-21.8)
12.8
(11.5-13.8)
21.9
(20.8-22.6)
35.3
(34.0-36.8)
656
20–39 years
22.9
(21.3-24.6)
13.1
(11.7-14.2)
24.2
(22.8-25.7)
39.6
(37.7-42.1)
770
40–59 years
21.9
(20.7-23.1)
11.8
(10.3-13.4)
23.2
(21.3-24.9)
38.5
(36.8-40.0)
777
60 years and older
16.1
(15.2-17.0)
7.00
(6.20-7.70)
17.8
(16.4-18.6)
33.9
(31.7-35.9)
943
Males
Total, 3 years and older
21.4
(20.5-22.4)
11.0
(9.90-11.6)
23.5
(22.3-24.5)
39.5
(37.9-40.9)
1737
3–5 years
14.4
(12.6-16.5)
7.80†
(4.40-9.50)
16.4
(14.3-19.1)
27.4†
(24.7-30.9)
71
6–11 years
21.7
(19.9-23.6)
12.2
(9.40-14.1)
22.2
(20.3-25.2)
36.0
(32.0-40.1)
157
12–19 years
22.1
(21.2-23.1)
12.9
(11.5-14.0)
23.2
(21.4-24.6)
37.0
(34.3-40.2)
323
20–39 years
24.8
(22.4-27.3)
13.9
(11.1-16.6)
25.8
(23.9-28.9)
42.4
(38.8-45.6)
312
40–59 years
22.6
(21.0-24.2)
11.4
(9.20-13.5)
24.5
(22.4-26.9)
40.0
(37.9-42.9)
407
60 years and older
15.7
(14.6-17.0)
6.90
(5.80-7.70)
17.5
(15.7-18.6)
33.8
(30.6-37.6)
467
Females
Total, 3 years and older
19.9
(19.2-20.7)
10.6
(9.90-11.4)
21.1
(20.1-22.1)
35.4
(33.9-36.7)
1841
3–5 years
16.6
(14.7-18.8)
8.70†
(6.20-13.1)
16.6
(14.7-18.9)
26.8†
(22.8-31.8)
61
6–11 years
21.3
(19.8-22.9)
11.0
(9.40-13.8)
21.7
(20.0-23.7)
34.2
(32.5-38.0)
143
12–19 years
20.2
(19.4-21.0)
12.6
(11.0-13.9)
21.3
(19.4-22.2)
32.4
(28.9-35.8)
333
20–39 years
21.3
(19.8-23.0)
12.3
(9.40-14.3)
22.4
(20.9-24.1)
36.5
(33.1-39.6)
458
40–59 years
21.2
(20.2-22.3)
12.6
(10.7-13.7)
22.0
(20.7-23.5)
36.6
(34.0-37.8)
370
60 years and older
16.4
(15.1-17.7)
6.90
(5.70-8.40)
17.9
(15.9-19.0)
33.8
(31.4-36.1)
476
† Estimate is subject to greater uncertainty due to small cell size.
